Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized fluticasone propionate vs oral prednisone for acute asthma exacerbations in Chinese children and adolescents
2015-004870-14Phase 3
- Sponsor
- GSK
- Start
- Aug 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluticasone propionate in asthma (2 arms), sponsored by GSK. Primary endpoint: Mean morning peak expiratory flow (PEF) over treatment assessment period.
02
Drugs
fluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on 2015-004870-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004870-14.